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Abstract
The My-10 monoclonal antibody has facilitated the search of haematopoietic stem cells by recognizing selectively the
human CD34 antigen. In the present work, My-10 immunoliposomes directed specifically against CD34q cells were
prepared, characterized and tested in vitro. Binding to target cells at 48C of immunoliposomes containing carboxyfluo-
rescein as aqueous marker was evaluated by flow cytometry and fluorescence microscopy. These immunoliposomes
demonstrated their capacity to bind specifically to CD34q cells. Studies have shown that 9 antibodiesrvesicle were
sufficient to obtain a good binding efficiency. The product was stable over one month at 48C in terms of leakage of
encapsulated carboxyfluorescein, particle size and antigen binding capacity. q 1998 Elsevier Science B.V.
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CD34 antibodies recognise a cell surface sialo-
mucin-like molecule that is selectively expressed by
only 1–4% of normal bone marrow cells, including
the earliest assayable haematopoietic progenitors
w x w x1,2 , and by vascular endothelial cells 3 . Its lack of
w xexpression by mature haematopoietic cells 4 makes
the CD34 antigen a logical candidate target molecule
to exploit for isolating haematopoietic stem cells as a
w xpart of autotransplantation procedures 5 , possible
gene therapy strategies, and the study of the functions
Abbreviations: mAb, monoclonal antibody; IL, immunolipo-
some; CF, carboxyfluorescein; MFI, mean fluorescence intensity;
 .GAM, F ab fragment goat-anti-mouse IgG; TL, total lipid2
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w xand regulation of blood forming cells 6 . Further-
more, although the function of CD34 molecule is
currently unknown, its engagement by antibodies has
no significant adverse effects on in vitro colony-for-
w xming cells 7 . Anti-CD34 monoclonal antibodies
 .mAbs have also been used for the antigenic analysis
w xof lymphohaematopoietic progenitor cells 8 , for the
w xenrichment of CD34q cells 9 as well as for
leukaemic blast characterization. The capillary en-
dothelium also contains CD34q cells and therefore
w xit has been used in angiogenesis studies 3 .
For a therapeutic intervention, the conjugation of
cell-specific mAbs to liposomes, referred to as im-
 .munoliposomes IL , provides the possibility for se-
w xlective drug delivery 10,11 . The advantages of IL as
w xdelivery system is now well established 12,13 . Many
methods for the covalent coupling of mAbs to lipo-
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w xsomes are available 10,14 , the coupled mAbs main-
tain their specificity for target antigens and the IL can
bind to the target cells by multivalent interactions
w x15 .
In the present work, IL directed specifically against
CD34q cells were prepared using the My-10 mAb
which facilitates the search of haematopoietic stem
cells by recognizing selectively the human CD34
w xantigen 16 . This mAb stains immature haematopoi-
etic precursor cells and all haematopoietic colony
w xforming cells from bone marrow 17 , cord blood and
w xadult peripheral blood 18 . My-10-IL, prepared by
the established SPDP coupling method, were charac-
terized and evaluated for their in vitro binding capac-
ity to KG-1a cells expressing the human CD34 anti-
gen. The effect of experimental variables on the
IL-cell interactions was quantified. The use of anti-
bodies to target liposomes to human CD34 antigen
expressing cells has not been reported previously.
 .  Egg phosphatidylcholine PC and N- 3- 2-pyri-
. .dyldithio -propionate -phosphatidylethanolamine
 .PDP-PE were obtained from Avanti Polar Lipids
 .Cholesterol Chol , fluorescein isothiocyanate, isomer
 .  .I FITC , N-succinimidyl-3- 2-pyridyldithio -
 .  .propionate SPDP and dithiothreitol DTT were
 .  .from Sigma St. Louis, MO . 5 6 -carboxyfluorescein
 .CF , obtained from Eastman-Kodak, was purified as
w xdescribed elsewhere 19 .
Anti My-10 clone and KG-1a cell line were ob-
tained from the American Type Culture Collection
 .Rockville, MD . Cells were grown as a suspension
 .culture in RPMI-1640 medium GIBCO , supple-
 .mented with 10% vrv heat-inactivated fetal bovine
serum, 2 mM L-glutamine, 1 mM sodium pyruvate,
100 units penicillin and 100 mgrml streptomycin
 .Biological Industries, Kibbutz Beth Haemek, Israel ,
at 378C in a humidified atmosphere of 5% CO and2
split 1:2 every two days.
 .FITC labelling of the My-10 mAb 2 mgrml was
obtained by incubation with 50 or 100 mg FITCrmg
mAb in 0.25 M carbonaterbicarbonate buffer NaCl
.0.1 M, pHs9.1 overnight at 48C, with gentle stir-
ring. The reaction mixture was light protected. The
unreacted dye was removed by gel filtration over
Sephadex G-50 spin columns. The FITC-mAb was
eluted in the void volume. The conjugation ratio
 .number of FITC molecules per mAb was deter-
mined by measuring the optical density at 280 and
495 nm, obtaining 6 or 12 FITC moleculesrmAb,
respectively.
The liposomes were prepared as described previ-
w xously 20 . Briefly, a lipid m ixture of
PCrCholrPDP-PE in a molar ratio 12r6r1 in chlo-
roform was dried, vacuum desiccated, and resus-
pended in PBS pHs7.4 or CF 50 mM in PBS. The
multilamellar vesicles were sequentially extruded
through polycarbonate membrane filters with 0.8, 0.4
 .and 0.1 mm pore size manufactured by Nucleopore
 .in an extrusion device Lipex Biomembranes in or-
der to obtain unilamellar vesicles. A solution of
 .My-10 or FITC-My-10 in PBS 2 mgrml was thio-
 .lated with SPDP SPDPrmAb 15r1 molar ratio .
The excess of SPDP was removed by Sephadex G-50
spin column and the product was reduced with DTT
50 mM at pHs4.5. As estimated spectrophotometri-
w xcally 21 , there were 4 PDP residues per mAb
molecule. The excess of DTT was removed from the
mAb using a Sephadex G-50. The protein with re-
duced thiols was kept in a N atmosphere and used2
immediately. Effective coupling was performed by
 .incubating liposomes 1.2 mmol with different
amounts of previously reduced mAb 0.2 to 1.6
.mgrml , for 24 h at 48C under stirring, to avoid
precipitation of the former. Free mAb was removed
by chromatography on Sepharose 4B. IL were eluted
in the first fractions as measured by phospholipid and
FITC fluorescence determinations.
The amount of monoclonal antibody coupled to
liposomes was calculated using FITC-My10-IL. The
lipid concentration was quantified by phosphorus
w xanalysis 22 . The protein was determined by FITC
fluorescence in comparison to a standard curve. The
number of vesicles was calculated as previously de-
w xscribed 23 . The vesicle size was characterized by
dynamic laser light scattering using a PCS41 optic
 .unit Malvern Autosizer IIC . The system reports a
polydispersity index as a measure of the particle size
distribution. The stability of liposomes and immuno-
liposomes was determined by measuring the release
 .of an entrapped dye CF . Fluorescence intensity
 .l s492; l s520 before and after liposomeex em
lysis with 5% Triton X-100 was measured with a
w xKontron SFM25 spectrofluorimeter 20 .
Cell binding assay was performed with exponen-
tially growing cells, rinsed twice in PBS supple-
 .mented with 1% bovine serum albumin BSA and
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resuspended at the final concentration of 106
cellsrml. For direct immunofluorescence assay, the
cell suspension was mixed with different amounts of
free My10, CF-entrapped My-10-IL or FITC-My10-
IL. All incubations were carried out during 30 min at
48C. Indirect immunofluorescence assay was per-
formed by further incubation with the FITC-con-
 .jugated F ab fragment goat-anti-mouse IgG2
 .  .GAM-FITC Kallestad, Austin, TX . Finally, cells
were rinsed twice with PBS prior to analysis. Cell
binding analysis was performed using an EPICS Elite
 .flow cytometer IZASA-Coulter, Spain , equipped
with an argon ion laser tuned at 488 nm as excitation
 .source. Green fluorescence FITC, CF was measured
through a BP 525 nm filter. All fluorescence mea-
surements were collected as a logarithmic signal.
Sample acquisition was stopped when the 90LS-fluo-
rescence histogram 10000 gated events were achieved.
All data were stored as listmode hardcopies and
analyzed with the EPICS Elite Workstation Software
v. 3.0.
The use of IL for target-specific drug delivery
requires a specific association with their target cells.
In order to achieve this goal, different factors should
be taken into account such as a sufficient quantity of
antibodies that must be bound to the liposomal sur-
face with their homing capacity preserved. Besides,
the integrity of the liposomes should be preserved
during the coupling process and the liposome-anti-
body complex must be stable on storage.
w xAs it has been demonstrated previously 24 , the
amount of mAbs bound per vesicle depends on the
mAbrliposomes concentration ratio in the incubation
 .mixture. Incubation of liposomes 1.2 mmol with
different initial mAb concentrations 0.2 to 1.6
.mgrml , allows to obtain IL with 9 to 72 mAb
moleculesrvesicle, as demonstrated by analysis of
the fluorescence of mAb FITC-My-10 bound to the
 .liposomes data not shown . The relationship between
the number of mAbrvesicle coupled and mAb con-
 .centration appeared to be linear rs0.9913 over a
 .concentration range from 0.2 to 1.6 mgrml Fig. 1 .
Previous works demonstrated that 1–2 Abrliposome
could be a sufficient antibody density to bind to
w xtarget cells 25 , therefore, IL bearing 9 mAbrvesicle
were used to assay cell binding.
The physicochemical properties of IL influence
w xnotably their behaviour in vitro 24 , therefore they
Fig. 1. The number of mAb moleculesrvesicle dependence on
mAb concentration in the incubation mixture means"S.D., ns
.  . 3 . PCrCholrPDP-PE 12r6r1, molar ratio liposomes 1.2
.mmol were incubated under N atmosphere for 24 h at 48C2
under stirring, with a fresh solution of thiolated FITC-IgG 0.2 to
.1.6 mgrml in PBS. Free mAb was removed by chromatography
on a Sepharose 4B.
were characterized prior to its immunoreactivity as-
say. The size of liposomes was found to be approxi-
mately 130 nm with a polydispersity index of 0.14
 .data not shown . The presence of antibody on the
liposome surface did not change significantly the
liposome size nor the permeability of liposomes us-
 .ing CF as aqueous marker data not shown . The
stability of the prepared IL was demonstrated by
controlling changes in vesicle size and CF retention.
IL could be stored at 48C in PBS during one month
 .without change in their size data not shown and CF
 .release 5–6% .
The immunoreactivity of My-10 mAb to KG-1a
cells was demonstrated by flow cytometry using a
 .  .second antibody GAM-FITC Fig. 2A . In order to
analyze immunospecific targeting of My-10-IL by
flow cytometry, these were incubated with KG-1a
cells using bare liposomes as a control. Incubations
were performed at 48C in order to inhibit uptake
processes. Direct immunofluorescence assay using
 .FITC-My10-IL 6 FITC moleculesrmAb did not
permit to demonstrate specific association of IL with
their target cells. Moreover, the further use of a
secondary GAM-FITC mAb showed fluorescence
histograms overlapping with negative control Fig.
.2A . The results are not related to a loss of antigen
specificity of the labelled My-10 as showed by flow
 .cytometry Fig. 3 . They should rather be related to
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 .Fig. 2. A Cytofluorimetric determination of My-10 IL, CF-IL and free My-10 mAb-FITC binding to KG-1a cells. Monoclonal antibody
 .  .  6 .My-10 FITC-conjugated 0.5 mgrml and My-10 FITC-IL 200 mM total lipid were incubated with cells 10 cellrml 30 min at 48C,
 .after washing twice with PBA cells were incubated with a secondary antibody FITC-conjugated F ab fragment, goat-anti-mouse IgG 302
 .min at 48C. Cells were direct immunostained CF-IL 200 mM total lipid 30 min at 48C and rinsed twice in PBA. Non-specific
fluorescence binding was measured incubating cells with bare CF-liposomes. X-axis represents the logarithm of green fluorescence
 .signal, and Y-axis represents cell count. B Specificity of the union immunoliposome-cell CD34q . Decrease of CF-IL-cell binding by
 6 .  .preincubation of cells with free My-10 mAb. KG-1a 10 cellrml were incubated 30 min at 48C with 200 mM CF-IL right plot or
 .liposomes as negative control left plot and rinsed twice in PBA. An aliquot of KG-1a cells was preincubated with free antibody 30 min
 .  .at 48C 5 mg , washed with PBA to eliminate unbound antibody and incubated with 200 mM CF-IL medium plot . The fluorescence
 .associated with cells was analyzed by flow cytometry. C Specificity of the union immunoliposome-cell CD34q . Binding of CF-IL on
 .  .  6 .various cell lines. HL60, CHO CD34y cells and KG-1a CD34q cells 10 cellrml were incubated with CF-IL or bare liposomes
 .200 mM as negative control. Fluorescence associated to cell was measured by flow cytometry. First plot of each uniparametric
histogram represents the negative control. X-axis represents the logarithm of green fluorescence signal, and Y-axis represents cell count.
the low amounts of antibody bound. An increase in
 .the My-10 mAb labelling 12 FITC moleculesrmAb
produced a loss of the antigen specificity data not
. w xshown , which is in accord with previous works 26 .
Fluorescent dyes can be entrapped into IL allowing
a signal enhancement in direct immunofluorescence
w xassays 26 . In this way, My-10-IL entrapping CF
 .CF-IL were prepared using the above coupling con-
ditions. Firstly, the stability of CF-IL in the presence
of cells was determined. Cells did not mediate leak-
age of liposomal CF during incubation at 48C data
.not shown . The specific labelling of cells stained
with CF-IL showed several fold increased resolution
 .above control Fig. 2A . The mean fluorescence in-
 .tensity MFI obtained by direct label of cells with
CF-IL was similar to that obtained with the system
 .My-10qGAM-FITC Fig. 2A . IL-cell interaction
was also confirmed by confocal microscopy data not
.shown . The photographs revealed that the IL were
present only on the cell surface, which was confirmed
by examination of optical cross-section through the
middle of the cells.
In order to show the specificity of the IL towards
the CD34 expressing cells, negative control binding
experiments were performed. CF-IL were incubated
with HL60 a human promyelocytic leukaemia cell
.  .line and CHO Chinese hamster ovary cells , which
 .did not express the CD34 antigen Fig. 2C . CHO
cells showed no significant fluorescence histograms
displacement and the non specific binding was infe-
rior to 5%. Unspecific binding to HL60 cells was
 .slightly higher ca. 20% , probably due to a possible
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Fig. 3. Cytofluorometric determination of the binding of FITC-
 .  5 .My-10 mAb 6 FITCrmAb to KG-1a cells 5=10 cells . Mean
 .fluorescence intensity MFI is plotted against FITC-My10 mAb
amount added. By direct immunofluorescence, using FITC-
 .  .labelled My-10 mAb 6 FITCrmAb v or indirect immuno-
 .fluorescence with a PE-conjugated F ab fragment goat-anti-2
 .  .  .mouse IgG GAM-PE secondary mAb 5 mg B .
w xphagocytic activity 27 . Furthermore, specific IL-cell
interactions were demonstrated by blocking the bind-
ing site by preincubation of the target cells with free
My-10 mAb. An inhibition of 80% of specific My-
10-IL-binding was obtained by previous incubation
 .of cells with 5 mg of free mAb Fig. 2B . A steric
hindrance might be an explanation for the inhibition
of IL binding to KG-1a cells.
In order to optimize the binding assay, some pa-
rameters such as the antibody density in the liposome
surface and the liposomal lipid concentration in the
w xincubation mixture were studied 12 . KG-1a cells
were incubated with different amounts of CF-IL 9
.mAbrvesicle . The IL bound to KG-1a cell line in a
 .dose-dependent manner Fig. 4A . Saturation of IL
binding was achieved at 400 mM TL. Controversial
results on the dependence of cell-binding to mAb
density at the liposome surface have been reported
w x12,25 . The degree of IL binding is dependent on the
number of mAb molecules present on the liposome
 .surface Fig. 4B . We found that an increase of the
mAb density from 9 to 72 mAbrvesicle arises the
binding efficiency, even though it shows a saturation
behaviour. Similar results were previously described
w x28 .
In conclusion, we have prepared immunolipo-
somes bearing My10 mAb which are directed against
human CD34 antigen expressing cells, as
haematopoietic stem cells. These immunoliposomes
have been characterized and their capacity to bind
specifically to target cells in vitro has been demon-
strated. The product was stable over one month at
48C in terms of leakage of encapsulated CF, particle
size and antigen binding capacity. Besides, our stud-
ies shown that 9 mAb per vesicle were sufficient to
obtain a good binding efficiency. Further studies will
be addressed to analyze the subsequent events which
follow IL-cell binding via the CD34-mAb interaction
that largely dictates the therapeutic potential of im-
munoliposomes as drug delivery system to
haematopoietic stem cells. Moreover, for in vivo
applications, the preparation of immunoliposomes
sterically stabilized by conjugation of mAb to the
w xPEG terminal polymer will be explored 28 .
 .Fig. 4. A Effect of the lipid concentration on the degree of
 .  .immunoliposomes binding to KG1-a. CF-IL 9 Abrvesicle v
 .or CF-liposomes B were incubated 30 min at 48C with KG-1a
 6 .  .cells 10 cellsrml and analyzed by flow cytometry. B Effect
of the antibody density on the immunoliposome binding. Im-
munoliposomes containing different amount of mAbrvesicle or
 .  6 .liposomes 200 mM were incubated with cells 10 cellsrml
during 30 min at 48C. Percentage of cell bound CF fluorescence
was determined by flow cytometry.
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